Cardinal Health (CAH) Stock Forecast & Price Target

Cardinal Health
Bull Case

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

• Cardinal Health, Inc. recently extended its pharmaceutical distribution agreement with CVS Health through June 2032, which reduces uncertainty around a key revenue stream and reinforces the stability of its business model by securing a major customer relationship for the long term.
• The company has demonstrated strong earnings momentum, beating analyst consensus estimates for the last four consecutive quarters, including the most recent quarter where it reported earnings per share of $2.91 against an estimate of $2.42, indicating consistent operational outperformance.
• Wall Street analysts maintain a consensus rating of Moderate Buy with an average price target of $266.56, which suggests significant upside potential from the current stock price of $232.96, reflecting confidence in the company's future growth trajectory.
• Cardinal Health, Inc. reaffirmed its fiscal 2027 non-GAAP earnings per share guidance of $12.40 to $12.60 and its long-term growth target of 12% to 14%, providing investors with a clear and optimistic outlook for future profitability.
• The stock exhibits a low beta of 0.50, meaning it is less volatile than the broader market, which can make it an attractive defensive holding for investors seeking stability during periods of market uncertainty.